SPOTLIGHT -
The FDA has approved Refocus Group's request to begin phase II clinical trials of its scleral implants and scleral spacing procedure for the surgical treatment of presbyopia.
ASCRS looks forward during milestone meeting
(EyePod) From idea to impact: Navigating ophthalmic innovation
Pearls to enhance patient comfort and streamline cataract surgery
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Seeking a solution to the anesthesia provider shortage
Case-controlled study explores hypothesized association between LASIK and early cataract surgery